Independent strategic judgement for decisions that shape the business.
Pressure-testing strategy, challenging assumptions and assessing growth opportunities before the market does.
I work with CEOs, founders, boards, and investors facing decisions with material consequences: growth, investment, transformation, partnerships, and competitive positioning.
Available as a retained board advisor or for defined projects, including UK market entry for international MedTech manufacturers.
My perspective is informed by more than 30 years of clinical, commercial, and executive leadership, including responsibility for a £500 million global orthopaedic portfolio at Smith & Nephew, executive leadership of JointMedica through FDA Breakthrough Device Designation and a transition to majority private equity ownership.
Better questions. Clearer decisions. Stronger businesses.
Start a Conversation
Experience that sharpens judgement.
30+ years
Clinical, commercial, and executive leadership across healthcare and international medical technology.
£500m global portfolio
Former Group Marketing Director, Smith & Nephew, with responsibility for a global orthopaedic portfolio valued at approximately £500 million.
FDA Breakthrough Device Designation
Managing Director, JointMedica, executive leadership through the May 2022 FDA Breakthrough Device Designation for its orthopaedic implant system.
Private equity ownership transition
Executive leadership through JointMedica’s transition to majority ownership by TPG Capital.
Leaders who value independent thinking and commercial honesty.
CEOs & Executive Teams
Strategic direction, commercial performance, and decisions with material business consequences.
Founders & Business Owners
Growth, investment, partnerships, and strategic change.
Boards & Investors
Independent commercial perspective, strategic challenge, and support on material business decisions.
Private Equity
Executive insight into portfolio company strategy, commercial performance, organisational change, and post-acquisition realities.
Medical Technology & Healthcare
Sector experience spanning clinical environments, product development, commercialisation, and international markets.
International MedTech Manufacturers
Entering the UK market: routes to market, distribution partners, and clinical and commercial stakeholder engagement.
Independent thinking. Commercial perspective. Practical recommendations.
01 - Strategic Advisory
Clarity when the decisions matter most.
Helping leadership teams decide where to compete, which opportunities to pursue and when to change direction.
Corporate and business strategy.
Competitive positioning.
Market entry and international development.
Investment and acquisition assessment.
Strategic partnerships.
Growth and diversification.
Board-level strategic advice.
Retained board advisor and non-executive roles.
02 - Business Transformation & Value Creation
Turning potential into commercial performance.
Identifying where value can be created and helping leadership teams establish the priorities to achieve it.
Strategic and commercial transformation.
Commercial performance and growth opportunities.
Organisational effectiveness and leadership alignment.
Post-acquisition priorities and integration.
Investment readiness and business repositioning.
Portfolio company development and value-creation strategies.
03 - Medical Technology & Healthcare
Industry knowledge built from the inside.
Bringing clinical understanding and international commercial leadership to businesses operating in complex healthcare markets.
Business strategy and commercial positioning.
Product development and market assessment.
International market development.
UK market entry for international manufacturers.
Go-to-market strategy.
Commercial due diligence.
Strategic partnerships and distribution.
Clinical, commercial, and institutional stakeholder engagement.
04 - AI Strategy & Business Transformation
Understanding where AI creates business value, and where it doesn’t.
Helping business leaders assess the opportunities, implications, and responsibilities of AI adoption.
Informed by Imperial Executive Education’s programme in AI for Business Transformation.
AI opportunity identification and prioritisation.
Business readiness and adoption strategy.
AI-enabled business transformation.
Workflow and organisational opportunities.
Governance, accountability, and human oversight.
AI implications for healthcare and regulated industries.
From clinical practice to international business leadership.

My career has taken me from the Royal Navy Medical Branch and NHS operating theatres into international medical technology, commercial leadership, and executive management.
Career progression
Royal Navy Medical Branch → NHS Senior Operating Department Practitioner → Zimmer UK → Smith & Nephew → JointMedica → Terence Smith Strategic Advisory.
At Smith & Nephew, I ultimately became Group Marketing Director, with responsibility for an international orthopaedic portfolio valued at approximately £500 million.
In 2016, I joined JointMedica as Managing Director. My executive responsibilities spanned corporate strategy, commercial development, clinical engagement, product development, regulatory progress, and strategic partnerships. I led the business through the FDA Breakthrough Device Designation for its orthopaedic implant system in May 2022 and its subsequent transition to majority ownership by TPG Capital.
Today, I bring that experience to independent advisory work with leaders facing important commercial and strategic decisions.
My continuing interests include artificial intelligence, robotics, and the future of healthcare transformation.
A straightforward philosophy
My reputation rests on telling you what you need to hear, not what you want to hear.
Good advice requires intellectual honesty, independent thinking, and the confidence to challenge assumptions, including uncomfortable ones.
My role is not to make the decision for you. It is to improve the quality of the decision you make.
A conversation before a commitment.
Initial conversations are confidential and carry no charge. Any subsequent engagement is agreed in advance, with clearly defined objectives, scope, and fees.
For businesses that want an experienced, independent voice over time rather than a one-off project, I also work as a retained board advisor: a fixed monthly arrangement, typically around a day a month, covering board or leadership meetings and support in between.
Let’s start with a conversation.
Tell me the decision you’re facing. I’ll reply within one working day with an honest view of whether I can help.
Terence Smith
Founder & Principal Advisor
Based in Worcestershire. Working internationally.
Terence Smith Strategic Advisory Ltd
Registered in England and Wales. Company number: 17541631.
Registered office: Brook House, Moss Grove, Kingswinford, West Midlands, DY6 9HS.
© 2026 Terence Smith Strategic Advisory Ltd. All rights reserved.
Privacy Notice
Terence Smith Strategic Advisory Ltd is responsible for personal information you send us. If you email us, we receive your name, contact details and anything you include in your message. We use this only to reply to your enquiry and, if we work together, to provide our services. Our legal basis is our legitimate interest in responding to you, or taking steps at your request before entering a contract. We do not sell your information. We share it only with providers who support our business, such as our email host and accountant. We keep enquiry correspondence only as long as needed, normally no more than two years if no engagement follows. You can ask to see, correct or delete your information, or object to how we use it, by emailing terence@tsmithadvisory.com. You can also complain to the Information Commissioner’s Office at ico.org.uk. This website does not use tracking cookies.
